Daewoong-Bio Inc.

Company Description

Daewoong Bio Inc., an independent affiliate of the Daewoong Group based in Seoul, South Korea, was company founded in 1983. Daewoong Bio produces cGMP complaint world-class products under quality guarantee systems. As a key manufacturer, Daewoong Bio provides APIs for global distribution and to multinational corporations developing original products. Daewoong Bio is also a full-service pharmaceutical company that utilizes Daewoong-Bio Inc. internal R&D, production facilities, and experienced marketing force with external global networks. Daewoong Bio is specialized to produce both world-class antibiotic APIs and general APIs.

Company Information

  • Contact Person:Ms. Heeran Kim
  • Telephone:
  • Operational Address:12, Bongeunsa-ro 114-gil, Gangnam-gu, Seoul, South Korea
  • Business Type:Manufacturer, Trading Company, Buying Office
  • Year Established:1983
  • Year Start Exporting:1983
  • Number Of Employees:301 - 500 People
  • Total Revenue:US$5 Million - US$10 Million
  • Trade Capacity:Eastern Asia : 46.00% Domestic Market : 38.00%
  • Production Capacity:No. of Production Lines : Above 10 Annual Output V
  • R&D Capacity:No. of R&D Staff :31 - 40 People
  • Main Products:UDCA,Meropenem,Lansoprazole,Rabeprazole,Ceftriaxone
  • Main Markets:Eastern Asia, Domestic Market, Western Europe, Sou
  • Location:Seoul, South Korea
  • Website:Visit website

Product

  • Cefaclor
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries